WBI Investments’s Bristol-Myers Squibb BMY Stock Holding History

WBI Investments’s Portfolio BMY Stock Details BMY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$1.62M	Sell	28,151 -12,674	-31%	-$728K	0.4%	63
2026 Q1	$2.48M	Sell	40,825 -30,250	-43%	-$1.76M	0.68%	27
2025 Q4	$3.83M	Buy	71,075 +11,272	+19%	+$542K	1%	12
2025 Q3	$2.7M	Buy	59,803 +40,237	+206%	+$1.88M	0.69%	22
2025 Q2	$906K	Buy	+19,566	New	+$960K	0.24%	129
2024 Q4	–	Sell	-42,886	Closed	-$2.22M	–	212
2024 Q3	$2.22M	Sell	42,886 -18,958	-31%	-$889K	0.53%	49
2024 Q2	$2.57M	Buy	61,844 +9,801	+19%	+$439K	0.62%	48
2024 Q1	$2.82M	Buy	+52,043	New	+$2.65M	0.59%	38
2022 Q3	–	Sell	-61,601	Closed	-$4.74M	–	117
2022 Q2	$4.74M	Sell	61,601 -6,589	-10%	-$502K	1.02%	26
2022 Q1	$4.87M	Buy	+68,190	New	+$4.58M	0.79%	37
2020 Q1	–	Sell	-160,188	Closed	-$10.3M	–	104
2019 Q4	$10.3M	Buy	160,188 +37,916	+31%	+$2.17M	1.1%	16
2019 Q3	$6.2M	Buy	+122,272	New	+$5.75M	0.59%	41
2015 Q3	–	Sell	-107,929	Closed	-$7.18M	–	163
2015 Q2	$7.18M	Buy	+107,929	New	+$7.11M	0.18%	103

Other funds holding BMY

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Norges Bank Oslo, Norway $1T AUM

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

WBI Investments's BMY Position: Q2 2026 in Review

WBI Investments reduced its Bristol-Myers Squibb (BMY) stake by 31% in Q2 2026, selling an estimated $728K and leaving 28,151 shares worth $1.62M. The position accounts for 0.4% of the portfolio, ranked #63.

WBI Investments first reported a position in BMY in Q2 2015 and has held it in 13 quarters since. The position peaked at $10.3M in Q4 2019. 2,521 funds tracked by Wall St. Rank hold BMY as of Q2 2026.

WBI Investments held 28,151 shares of Bristol-Myers Squibb worth $1.62M as of Q2 2026.
WBI Investments sold 12,674 Bristol-Myers Squibb shares in Q2 2026, an estimated $728K.
Bristol-Myers Squibb made up 0.4% of WBI Investments's portfolio in Q2 2026, its #63 holding.
WBI Investments first reported a position in Bristol-Myers Squibb in Q2 2015 and has held it in 13 quarters since.
WBI Investments's Bristol-Myers Squibb position peaked at $10.3M in Q4 2019.
2,521 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q2 2026.

Based on WBI Investments's 13F filing for Q2 2026, filed 11 Aug 2026.